XML 106 R24.htm IDEA: XBRL DOCUMENT
v3.19.3

Segment Information | 9 Months Ended
--- | ---
Sep. 27, 2019
Segment Reporting [Abstract] |
Segment Information | SEGMENT INFORMATION The Company operates and reports its results in four separate business segments consisting of the Life Sciences, Diagnostics, Dental/Envista and Environmental & Applied Solutions segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income and expense, interest and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. Intersegment amounts are not significant and are eliminated to arrive at consolidated totals. Segment results are shown below ($ in millions):
| Three-Month Period Ended |  | Nine-Month Period Ended
| September 27, 2019 |  | September 28, 2018 |  | September 27, 2019 |  | September 28, 2018
Sales: |  |  |  |  |  |  |
Life Sciences | $ | 1,695.6 |  |  | $ | 1,596.7 |  |  | $ | 5,035.1 |  |  | $ | 4,677.9 |
Diagnostics | 1,601.9 |  |  | 1,502.5 |  |  | 4,757.0 |  |  | 4,573.1 |
Dental / Envista | 659.3 |  |  | 679.5 |  |  | 2,031.1 |  |  | 2,085.5 |
Environmental & Applied Solutions | 1,080.5 |  |  | 1,074.4 |  |  | 3,250.6 |  |  | 3,193.0 |
Total | $ | 5,037.3 |  |  | $ | 4,853.1 |  |  | $ | 15,073.8 |  |  | $ | 14,529.5 |
Operating profit: |  |  |  |  |  |  |
Life Sciences | $ | 342.5 |  |  | $ | 312.8 |  |  | $ | 995.5 |  |  | $ | 875.6 |
Diagnostics | 266.0 |  |  | 235.1 |  |  | 782.0 |  |  | 757.4 |
Dental / Envista | 78.7 |  |  | 86.1 |  |  | 206.4 |  |  | 241.8 |
Environmental & Applied Solutions | 256.5 |  |  | 254.3 |  |  | 761.3 |  |  | 732.5 |
Other | (108.9 | ) |  | (57.6 | ) |  | (302.8 | ) |  | (166.1 | )
Total | $ | 834.8 |  |  | $ | 830.7 |  |  | $ | 2,442.4 |  |  | $ | 2,441.2 |
Segment identifiable assets are shown below ($ in millions):
| September 27, 2019 |  | December 31, 2018
Life Sciences | $ | 22,115.0 |  |  | $ | 22,122.4 |
Diagnostics | 14,175.1 |  |  | 14,031.1 |
Dental / Envista | 6,009.5 |  |  | 5,897.3 |
Environmental & Applied Solutions | 4,741.3 |  |  | 4,637.3 |
Other | 14,490.2 |  |  | 1,144.4 |
Total | $ | 61,531.1 |  |  | $ | 47,832.5 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration